Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials. - Li X; Han J; Shi X; Bi Z; Liu J (Archives of osteoporosis, 2023)